Concepedia
Statistics
Publications
1
Citations
14
H-Index
Active since
2023
Affiliations
University of Washington Bothell(Current)
Kelsi Willis is an author at University of Washington Bothell.
Publications per year
2023–2023
HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer
Devra J. Olson, Janelle Taylor, Kelsi Willis et al. · Cancer Research Communications · 2023 · 14 citations · Full text
1–1 of 1